Puma Biotech 'Is The Real Deal,' Overcomes Controversy With Positive FDA Panel Vote

By: via Benzinga
Puma Biotechnology Inc (NASDAQ: PBYI) investors got some major vindication Wednesday when the FDA’s Oncologic Drugs Advisory ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.